Data management and confidentiality
cancer, psychiatric, cancer stage
ADVERSE EVENTS, CANCER, HAND PRESENTATION, METASTASIS
Clinical data (age, gender, education, employment status, marital status, cancer diagnosis, metastasis, cancer stage, history of cancer treatment, current cancer treatment, current medication, psychiatric history, ECOG PS, and questionnaire data) obtained from this study will be managed anonymously by a data manager. All participants will be assigned a unique subject identification number (ID). All data will be coded by ID; all study-related documents will be anonymous. The consent forms containing participants’ signatures and master lists linking participants’ names to ID numbers will be stored in secure servers or in locked office filing cabinets at each research facility. Researchers will analyze the stored data. The principal investigator and researchers who will analyze the data will have access to the final dataset. The results will be submitted for peer-reviewed publication and presentation at local, national, and international scientific meetings and conferences.Since there are few adverse events expected during this study and it is not an invasive study as defined by the Ethical Guidelines for Medical and Health Research Involving Human Subjects [